Professor of Neurology, University Mich Medical School
Neurology
Dr. Eva L. Feldman, MD
|
|
Give Review
Doctor Eva L. Feldman, MD practices Neurology. He went to University of Michigan Medical School. He received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Whos Who in Medicine and Healthcare". Feldman has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.' He accepts all Medicare patients.
Publications
- Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease.
- The role of endoplasmic reticulum stress in hippocampal insulin resistance.
- Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into Disease mechanisms.
- Inflammation as a Therapeutic Target for Diabetic Neuropathies.
- Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes.
- Progress in Inflammatory neuropathy -the legacy of Dr Jack Griffin.
- Gender-specific differences in Diabetic neuropathy in BTBR ob/ob mice.
- The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis.
- Circuits and Circuit Disorders: Approaches to Neuromodulation: Call for Papers and New Initiative With the American Neurological Association and the Annals of Neurology.
- Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis.
- The dual roles of immunity in ALS: Injury overrides protection.
- The evaluation of distal symmetric Polyneuropathy: utilisation and expenditures by community neurologists.
- Therapeutic hypothermia and targeted temperature management after cardiac arrest-reply.
- Autocrine Production of IGF-I Increases Stem Cell-Mediated Neuroprotection.
- Analysis of graft survival in a trial of stem cell transplant in ALS.
- Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes.
- Global Metabolomic and Isobaric Tagging Capillary Liquid Chromatography-Tandem Mass Spectrometry Approaches for Uncovering Pathway Dysfunction in Diabetic Mouse Aorta.
- BTBR ob/ob mice as a novel Diabetic neuropathy model: Neurological characterization and gene expression analyses.
- Hyperglycemia- and Neuropathy-induced changes in mitochondria within sensory nerves.
- Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron Disease.
- Role of neurologists and diagnostic tests on the management of distal symmetric Polyneuropathy.
- Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth Disease.
- Therapeutic Hypothermia After Cardiac Arrest Without Return of Consciousness: Skating on Thin Ice.
- Diffusion tensor imaging of the sural Nerve in normal controls.
- Effect of Pain in pediatric inherited neuropathies.
- A Brighter Future for Patients With Amyotrophic Lateral Sclerosis Through Imaging?
- Intraspinal Neural Stem Cell Injections in ALS Subjects: Phase I Trial Outcomes.
- Multimodal MRI as a diagnostic biomarker for amyotrophic lateral Sclerosis.
- Stem cell therapies for amyotrophic lateral Sclerosis: Recent advances and prospects for the future.
- ER stress in Diabetic peripheral neuropathy: A new therapeutic target.
- The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish.
- Expenditures in the elderly with peripheral Neuropathy: Where should we focus cost-control efforts?
- Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-Up Cohort: A pilot study.
- Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a Systematic review and individual patient data meta-analysis.
- Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysf...
- Intraspinal Stem Cell Transplantation in ALS: A Phase I Trial, Cervical Microinjection and Final Surgical Safety Outcomes.
- The metabolic Syndrome and neuropathy: Therapeutic challenges and opportunities.
- An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral Sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
- 25 years of neuroimaging in amyotrophic lateral Sclerosis.
- Effects of triple antioxidant therapy on measures of cardiovascular Autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial.
- Spontaneous laryngeal reinnervation following Chronic recurrent laryngeal nerve injury.
- Increased Axonal Regeneration and Swellings in Intraepidermal Nerve Fibers Characterize Painful Phenotypes of Diabetic Neuropathy.
- Diabetic cardiac Autonomic neuropathy: Insights from animal models.
- Two dynamin-2 genes are required for normal zebrafish development.
- Identification of epigenetically altered genes in sporadic amyotrophic lateral Sclerosis.
- NeuroMuscular junction abnormalities in DNM2-related centronuclear myopathy.
- Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral Nervous system oxidative stress in a murine model of type 2 diabetes.
- Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced Neuropathy.
- Additional perspectives on transforming science into medicine.
- Diabetic neuropathy: one Disease or two?
- Central Nervous system endoplasmic reticulum stress in a murine model of type 2 diabetes.
- Enhanced glucose control for preventing and treating Diabetic neuropathy.
- Insulin-like growth factors in the peripheral Nervous system.
- Diabetic neuropathy: clinical manifestations and current treatments.
- Capturing cases of distal symmetric Polyneuropathy in a community.
- Altered Excitation-inhibition Balance in the Brain of Patients with Diabetic Neuropathy.
- Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral Sclerosis.
- Neurodegeneration and early lethality in SOD2-deficient mice: a comprehensive analysis of the central and peripheral Nervous systems.
- Insulin resistance in the Nervous system.
- Translational stem cell therapy for amyotrophic lateral Sclerosis.
- The Evaluation of Distal Symmetric Polyneuropathy: A Physician Survey of Clinical Practice.
- Potential for promoting recurrent laryngeal Nerve regeneration by remote delivery of viral gene therapy.
- The identification of gene expression profiles associated with progression of human Diabetic neuropathy.
- Skeletal muscle weakness due to deficiency of Cu,Zn superoxide dismutase is associated with loss of functional innervation.
- Stem cell technology for neurodegenerative Diseases.
- Ontology-based Brucella vaccine literature indexing and Systematic analysis of gene-vaccine association network.
- Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful Neuropathy of type 2 diabetes.
- Comment: Career guidelines promote neurologist satisfaction.
- Hyperinsulinemia Induces Insulin Resistance in Dorsal Root Ganglion Neurons.
- Effect of mild hyperglycemia on Autonomic function in obstructive sleep apnea.
- Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS.
- Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse: A Model of Type 2 Diabetes.
- Cortical neurons develop insulin resistance and blunted akt signaling: a potential mechanism contributing to enhanced ischemic Injury in diabetes.
- Evidence-based guideline: Treatment of painful Diabetic neuropathy-report of the american association of neuromuscular and electrodiagnostic medicine, the american aca...
- Computational methods for identifying a layered allosteric regulatory mechanism for ALS-causing mutations of Cu-Zn superoxide dismutase 1.
- Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs.
- The pleotrophic effects of insulin-like growth factor-I on human spinal cord neural progenitor cells.
- The role of MTMR14 in autophagy and in muscle Disease.
- Accelerated neuritogenesis and maturation of primary spinal motor neurons in response to nanofibers.
- Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita Diabetic mice.
- Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.
- The management of Diabetic neuropathy in CKD.
- Visualization of mitochondrial DNA replication in individual cells by EdU signal amplification.
- Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.
- Hyperlipidemia: a new therapeutic target for Diabetic neuropathy.
- Mitochondrial DNA (mtDNA) Biogenesis: Visualization and Duel Incorporation of BrdU and EdU Into Newly Synthesized mtDNA In Vitro.
- Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.
- Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.
- SUMOylation of the mitochondrial fission protein Drp1 occurs at Multiple nonconsensus sites within the B domain and is linked to its activity cycle.
- Dyslipidemia-induced Neuropathy in mice: the role of oxLDL/LOX-1.
- Elevated triglycerides correlate with progression of Diabetic neuropathy.
- Computational methods for predicting sites of functionally important dynamics.
- Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary: Advances toward measuring diabetic retinopathy and neuropathy: from the bench...
- Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in Neuropathy of impaired glucose regulation.
- Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.
- Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
- Disorders of cranial nerves IX and X.
- Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
- Transcriptional networks of murine Diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns.
Schools
University of Mi Med Sch
Beaumont Hospital Royal Oak
Johns Hopkins Hospital
University Of Michigan
Procedures Preformed
- EMG (Electromyography)
Conditions Treated
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Golden Rule
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- NGS CoreSource
- Paramount
- PHP-Physicians Health Plan
- Priority PPO
- Sagamore Plus
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
Education
-
Johns Hopkins University -
William Beaumont Hospital -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1073602942 | |
| NPPES Provider LastName | FELDMAN | |
| NPPES Provider FirstName | EVA | |
| NPPES Provider ZIPCode | 481095322 | |
| NPPES Provider State | MI | |
| Specialty Description | Neurology | |
| Total Claim Count | 109.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073602942 |
| Last Name Of The Provider | FELDMAN |
| First Name Of The Provider | EVA |
| View All |
Similar Doctors
|
|
Dr. Steven M. Leber, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martha D. Carlson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Teener, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin M. Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lewis B. Morgenstern, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen Dayalu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James R. Weintraub, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alicia R. Prestegaard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary W. Gallagher, MD |
|
|
Dr. Robert R. Coleman, MD |
|
|
Dr. Erin E. Neil Knierbein, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily R. Nurre, MD |
|
|
Dr. Padmaja Sudhakar, MD |
|
|
Dr. Jonathan D. Snider, MD
This Doctor is OpenDoctor Recommended.
|